Le Lézard
Classified in: Health
Subjects: SVY, BFA

Innovative Partnership and Business Collaborations Driving Health Industry Transformation


WASHINGTON, Dec. 12, 2018 /PRNewswire/ -- 2018 has seen extensive health-focused merger and partnership activity, with nearly 840 deals announced as of Q3. Players new to the industry are driving innovation in the traditionally cautious health and life sciences sectors, with unanticipated and innovative alliances poised to revolutionize health care. McDermott Will & Emery is at the forefront of this activity, helping progressive leaders redefine and navigate the health care landscape through Collaborative Transformations ? game-changing partnerships that drive bold and creative business solutions.

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8207752-mcdermott-innovative-partnership-business-collaborations/

Through collaborative transformations, health and life sciences organizations are embracing new ways of engaging and working with partners both from inside and outside the health sector. This is ultimately helping to improve quality of care, increase operational efficiencies and reduce costs, while dramatically redefining what consumers have come to expect from their health care experience.

"Visionaries are exploring new approaches to develop and bring pioneering health care solutions to market," said Stephen W. Bernstein, partner and International Head of McDermott's Health Industry Advisory Group. "Whether organizations are looking to collaborate across industries or across the world, our team has the experience and industry knowledge to help them align different perspectives, cultures, risk tolerance and business processes as these new relationships begin. We're passionate about the results our clients are achieving, and are excited to continue working closely with them as they drive to improve health care through these collaborative transformations."

Whether fostering breakthrough mergers, acquisitions and affiliations, clearing the way for innovative products and services, or navigating strategic investments and alliances across industries and borders, McDermott is committed to helping clients achieve the transformations they seek. Examples of how the Firm has assisted clients in these undertakings:

McDermott Will & Emery is the nation's leading health care law firm. The Health Industry Advisory group is the only health practice to receive top national rankings from US News ? Best Lawyers "Best Law Firms," Chambers USA, The Legal 500 US, and Law360. The practice was also recognized by Chambers as "Health Team of the Year" in 2010, 2013 and 2017. Since 2017, McDermott has also taken the top spot in PitchBook's League Tables as the most active firm for health care private equity.

At the heart of our practice is a skilled and dedicated team of lawyers with cross-functional and cross-border capabilities. To learn more about our team and our approach to Collaborative Transformation, visit MWE.com/CollaborativeTransformation. Also join us for our Hospital/Health System Collaborative Transformation Forum at the at 2019 J.P. Morgan Healthcare Conference, January 7?9, 2019 in San Francisco. Event and registration details are available here.

About McDermott Will & Emery
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, San Francisco, Seoul, Silicon Valley and Washington, DC. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.

 

McDermott Will & Emery helps progressive leaders redefine and navigate the health care and life sciences landscape through Collaborative Transformations ? game-changing partnerships that drive bold and creative business solutions.

 

Health care organizations are increasingly seeing the value of partnering - sometimes in unexpected ways. Learn how to make these collaborative transformations both seamless and successful.

 

 

 

 

SOURCE McDermott Will & Emery


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: